ABSTRACT
Background: Coronavirus disease 2019 (COVID-19) can cause asymptomatic, mild upper respiratory tract symptoms and pneumonia in young persons. How the disease will progress in each patient is still unknown. Therefore, we aimed to investigate the prognostic markers of the development of pneumonia and the clinical characteristics of patients under 65 years with COVID-19 confirmed by a positive reverse transcriptase polymerase chain reaction test. Methods: In this retrospective study, a total of 271 patients admitted in our unit were included. The patients were divided into two groups, those who did and those who did not develop pneumonia. Their clinical features, treatment protocols, and laboratory parameters were recorded retrospectively. Results: Pneumonia developed in 67.9% (n = 184) of the cases. The age in the pneumonia group was higher than that in the non-pneumonia group (p < 0.001). In the logistic regression analysis, the symptom and co-morbidity status were examined according to the presence of pneumonia; hypertension (HT) (OR: 4525, 95% CL: 1,494-13,708) was the most important risk factor for pneumonia. When age and laboratory values were examined according to the presence of pneumonia, advanced age (OR: 1.042, 95% CL: 1.01-1.073), low albumin (OR: 0.917, 95% CL: 0.854-0.986), and high troponin (OR: 1.291, 95% CL: 1.044-1.596) were identified as risk factors for pneumonia. Conclusion: In this article, HT (22.3%, P < 0.001) has been considered as an important risk factor, whereas association of diabetes mellitus (21.2%, P 0.029) and smoking (25.0%, P 0.038) was also significant. The median age of the group was 51 (41.5-58) in the group developing pneumonia and 41 (30-48) in the non-developing group. Young patients with these predictive factors should be more carefully evaluated by further diagnostic procedures, such as thoracic computed tomography.
ABSTRACT
The purpose of our study was to determine the changes in the smoking habits of active smokers hospitalized with Coronavirus disease-19 (Covid-19). We conducted a single-center, retrospective research on smokers hospitalized with Covid-19 between March 2020 and June 2020. A total of 105 patients were included in the study. The age, gender, comorbidities, cigarette pack per year, PCR test results of the patients were recorded from the patient files. Patients were approached by telephone and a questionnaire was applied to them to evaluate smoking habits following discharge. A total of 105 patients participated in the study. 42 (40.0%) were female and the mean age of the patients was 39.80 ± 12.66 (width, 16-69) years. Patients smoked 14.51 ±13.88 packs of cigarettes a year on average. Of the patients, 13.33% quit smoking. In our study, it was determined that after having Covid -19, 86.66% (n: 91) of the patients continued to smoke. Of those who did not quit smoking, 53.8% stated that they reduced smoking compared to the past, 76.9% thought to quit smoking, and 48.4% said they needed professional support to quit smoking. In addition, 38.5% of those who didn't quit smoking stated that they believed they were caught Covid-19 due to smoking. Raising awareness that quitting smoking reduces the risks and complications of Covid-19 and activating new smoking cessation programs may help individuals to quit smoking during the pandemic. [ABSTRACT FROM AUTHOR] Copyright of Eastern Journal of Medicine is the property of Yuzuncu Yil University, Faculty of Medicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)